Generics in the United States

Summary

Datamonitor's Generics in the United States industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

• Contains an executive summary and data on value, volume and/or segmentation
• Provides textual analysis of the industry's recent performance and future prospects
• Incorporates in-depth five forces competitive environment analysis and scorecards
• Includes a five-year forecast of the industry
• The leading companies are profiled with supporting key financial metrics
• Supported by the key macroeconomic and demographic data affecting the market

Highlights

• Detailed information is included on market size, measured by value and/or volume
• Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape

Why you should buy this report

• Spot future trends and developments
• Inform your business decisions
• Add weight to presentations and marketing materials
• Save time carrying out entry-level research

Market Definition
The value of the generics market consists of all sales of generics drugs at ex-manufacturers prices. The market does not include animal healthcare products. Datamonitor defines a generic as a product, which is an officially approved copy of an original product whose patent has expired, marketed either as a brand or using the generic name. This definition excludes multi-source copy products that make up much of markets such as India, Spain and Italy. All currency conversions have been calculated at constant 2006 average exchange rates.
Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Content